Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM
- PMID: 28271625
- DOI: 10.1002/ejhf.780
Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM
Abstract
Aims: The purpose of this study is to describe disease presentation, co-morbidities, diagnosis and initial therapeutic management of patients with peripartum cardiomyopathy (PPCM) living in countries belonging to the European Society of Cardiology (ESC) vs. non-ESC countries.
Methods and results: Out of 500 patients with PPCM entered by 31 March 2016, we report on data of the first 411 patients with completed case record forms (from 43 countries) entered into this ongoing registry. There were marked differences in socio-demographic parameters such as Human Development Index, GINI index on inequality, and Health Expenditure in PPCM patients from ESC vs. non-ESC countries (P < 0.001 each). Ethnicity was Caucasian (34%), Black African (25.8%), Asian (21.8%), and Middle Eastern backgrounds (16.4%). Despite the huge disparities in socio-demographic factors and ethnic backgrounds, baseline characteristics are remarkably similar. Drug therapy initiated post-partum included ACE inhibitors/ARBs and mineralocorticoid receptor antagonists with identical frequencies in ESC vs. non-ESC countries. However, in non-ESC countries, there was significantly less use of beta-blockers (70.3% vs. 91.9%) and ivabradine (1.4% vs. 17.1%), but more use of diuretics (91.3% vs. 68.8%), digoxin (37.0% vs. 18.0%), and bromocriptine (32.6% vs. 7.1%) (P < 0.001). More patients in non-ESC vs. ESC countries continued to have symptomatic heart failure after 1 month (92.3% vs. 81.3%, P < 0.001). Venous thrombo-embolic events, arterial embolizations, and cerebrovascular accidents were documented in 28 of 411 patients (6.8%). Neonatal death rate was 3.1%.
Conclusion: PPCM occurs in women from different ethnic backgrounds globally. Despite marked differences in socio-economic background, mode of presentation was largely similar. Embolic events and persistent heart failure were common within 1 month post-diagnosis and required intensive, multidisciplinary management.
Keywords: Definition; Peripartum cardiomyopathy; Registry; Thrombotic events.
© 2017 The Authors. European Journal of Heart Failure © 2017 European Society of Cardiology.
Comment in
-
Peripartum cardiomyopathy for the clinician: the known and the unknown.Eur J Heart Fail. 2017 Sep;19(9):1142-1144. doi: 10.1002/ejhf.840. Epub 2017 Jun 26. Eur J Heart Fail. 2017. PMID: 28653358 No abstract available.
Similar articles
-
Peripartum cardiomyopathy in low- and middle-income countries.Best Pract Res Clin Obstet Gynaecol. 2024 Mar;93:102476. doi: 10.1016/j.bpobgyn.2024.102476. Epub 2024 Feb 17. Best Pract Res Clin Obstet Gynaecol. 2024. PMID: 38395024 Review.
-
Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: A study of the ESC EORP PPCM registry.Int J Cardiol. 2024 Mar 1;398:131596. doi: 10.1016/j.ijcard.2023.131596. Epub 2023 Nov 17. Int J Cardiol. 2024. PMID: 37979788
-
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry.Eur Heart J. 2020 Oct 14;41(39):3787-3797. doi: 10.1093/eurheartj/ehaa455. Eur Heart J. 2020. PMID: 32840318 Free PMC article.
-
Peripartum Cardiomyopathy.Circulation. 2016 Apr 5;133(14):1397-409. doi: 10.1161/CIRCULATIONAHA.115.020491. Circulation. 2016. PMID: 27045128 Review.
-
EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM.Eur J Heart Fail. 2014 May;16(5):583-91. doi: 10.1002/ejhf.68. Epub 2014 Mar 3. Eur J Heart Fail. 2014. PMID: 24591060
Cited by
-
Heart failure due to peripartum cardiomyopathy presenting in the first week of puerperium-A case series from Nepal.Clin Case Rep. 2024 May 31;12(6):e9043. doi: 10.1002/ccr3.9043. eCollection 2024 Jun. Clin Case Rep. 2024. PMID: 38827942 Free PMC article.
-
Sex-related similarities and differences in responses to heart failure therapies.Nat Rev Cardiol. 2024 Jul;21(7):498-516. doi: 10.1038/s41569-024-00996-1. Epub 2024 Mar 8. Nat Rev Cardiol. 2024. PMID: 38459252 Review.
-
Characterization of Non-Ischemic Dilated Cardiomyopathy in a Native Tanzanian Cohort: MOYO Study.Glob Heart. 2024 Feb 29;19(1):26. doi: 10.5334/gh.1298. eCollection 2024. Glob Heart. 2024. PMID: 38434152 Free PMC article.
-
Thromboembolism in peripartum cardiomyopathy: a systematic review.J Thorac Dis. 2024 Jan 30;16(1):645-660. doi: 10.21037/jtd-23-945. Epub 2024 Jan 16. J Thorac Dis. 2024. PMID: 38410599 Free PMC article. Review.
-
Biomarkers in Peripartum Cardiomyopathy-What We Know and What Is Still to Be Found.Biomolecules. 2024 Jan 12;14(1):103. doi: 10.3390/biom14010103. Biomolecules. 2024. PMID: 38254703 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous